Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on October 26, 2026

Oct. 26, 2026

Newsweek Places KFSH in Top 4% of World’s Smart Hospitals for Digital Maturity and AI

Indeterminate GlobeNewswire

Oct. 26, 2026

Kraig Labs Moves Beyond Bold Breakthrough

Indeterminate GlobeNewswire

Oct. 26, 2026

Coherus Oncology to Report Third Quarter 2026 Financial Results on November 9, 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

U.S. Renal Care Presents Analysis of VOICE Trial Demonstrating Favorable Safety Outcomes for Patients Treated with Vadadustat Versus an ESA During a Late-Breaking Session at American Society of Nephrology Kidney Week

Indeterminate GlobeNewswire

Oct. 26, 2026

NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three Countries

Indeterminate GlobeNewswire

Oct. 26, 2026

Longeveron Announces Updated Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)

Indeterminate GlobeNewswire

Oct. 26, 2026

Niki BioSolutions Announces New York State Approval for Its APOE Genotyping Test Using Dried Blood Spots, Plasma, and Urine

Indeterminate GlobeNewswire

Oct. 26, 2026

X9 Receives FDA Breakthrough Device Designation for Investigational Dialysis Cannulation System and Completes Second Clinical Study

Indeterminate GlobeNewswire

Oct. 26, 2026

SRX Global Announces Activation of the University of California, Davis as a Clinical Trial Site for CERo Therapeutics’ Ongoing Phase 1 CERTAIN-T Trial of CER-1236 in Hematologic Malignancies

Indeterminate GlobeNewswire

Oct. 26, 2026

Imprivata Recognized for the First Time in the Gartner® Magic Quadrant™ for Privileged Access Management

Indeterminate GlobeNewswire

Oct. 26, 2026

Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call

Indeterminate GlobeNewswire

Oct. 26, 2026

Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market

Indeterminate GlobeNewswire

Oct. 26, 2026

More Than 1 in 10 People Receive Medically Actionable Genetic Results Through 23andMe, Analysis of Nearly 6 Million Participants Finds

Indeterminate GlobeNewswire

Oct. 26, 2026

Avacta Group plc: Faridoxorubicin Treatment Results in Near Doubling of Progression-Free Survival and Clinically Meaningful Tumor Shrinkage in Most Patients with Salivary Gland Cancers

Indeterminate GlobeNewswire

Oct. 26, 2026

Medicenna Reports Potent CD122 Blockade and Extended Survival with MDNA209 in Preclinical Models of Autoimmune Disease

Indeterminate GlobeNewswire

Oct. 26, 2026

Ambros Therapeutics Announces Planned Interim Analysis of Phase 3 Clinical Trial Following FDA Feedback

Indeterminate GlobeNewswire

Oct. 26, 2026

Daré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly

Indeterminate GlobeNewswire

Oct. 26, 2026

The Vitamin Gummy Supplements Market for Children Is Projected to Grow Rapidly at a 9.8% CAGR Until 2030

Indeterminate EIN Presswire

Oct. 26, 2026

Competitive Landscape of the Artificial Intelligence in Healthcare Market Examined Among Top Global Companies

Indeterminate EIN Presswire

Oct. 26, 2026

Propanc Biopharma Publishes New Data: PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells & Restores Therapeutic Vulnerability

Indeterminate GlobeNewswire